Persistence Market Research Company
Enquire Now Report Sample

Growth Factors Market Size, Share, and Growth Forecast for 2025 - 2032

Growth Factors Market by Product (Transforming, Epidermal, Platelet-derived, Fibroblast), Grade, Application, Expression Host System, Mode of Action, Species Origin, End User, and Regional Analysis

Comprehensive Snapshot for Growth Factors Market Including Regional and Country Analysis in Brief.

Industry: Healthcare

Format: PPT*, PDF, EXCEL

Last Updated: 9 December 2024

ID: PMRREP4456

Number of Pages: 194

Buy Now
Request Customisation

Table of Content

  1. Executive Summary
    1. Global Growth Factors Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 – 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Growth Factors Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025–2032
    3. Global Growth Factors Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 – 2032
        1. Transforming Growth Factors (TGF)
          1. Activin
          2. Bone Morphogenetic Proteins (BMPs)
          3. TGF-beta Proteins
        2. Epidermal Growth Factors (EGFs)
        3. Platelet-derived Growth Factors (PDGFs)
        4. Fibroblast Growth Factors (FGFs)
        5. Insulin-like Growth Factors (IGFs)
        6. Vascular Endothelial Growth Factors (VEGFs)
        7. Hepatocyte Growth Factors (HGFs)
        8. Tumor Necrosis Factors (TNFs)
        9. Interleukins
        10. Others
      4. Market Attractiveness Analysis: Product
    4. Global Growth Factors Market Outlook: Grade
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Grade, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 – 2032
        1. GMP Grade
        2. NON-GMP Grade
      4. Market Attractiveness Analysis: Grade
    5. Global Growth Factors Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 – 2032
        1. Oncology
        2. Hematology
        3. Wound Healing
        4. Dermatology
        5. Cardiovascular Disease and Diabetes
        6. Cell Therapy and EX-vivo Manufacturing
        7. Others
      4. Market Attractiveness Analysis: Application
    6. Global Growth Factors Market Outlook: Expression Host System
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Expression Host System, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Expression Host System, 2025 – 2032
        1. Animal-derived
        2. Recombinant
      4. Market Attractiveness Analysis: Expression Host System
    7. Global Growth Factors Market Outlook: Mode of Action
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Mode of Action, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 – 2032
        1. Angiogenic
        2. Anti-apoptotic
        3. Mitogenic
      4. Market Attractiveness Analysis: Mode of Action
    8. Global Growth Factors Market Outlook: Species Origin
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Species Origin, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 – 2032
        1. Human
        2. Pig
        3. Mouse
        4. Rat
      4. Market Attractiveness Analysis: Species Origin
    9. Global Growth Factors Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 – 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 – 2032
        1. Pharmaceutical and Biotechnology Companies
        2. Research Centers and Academic Institutes
        3. Contract Research Organizations
      4. Market Attractiveness Analysis: End User
  5. Global Growth Factors Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 – 2024
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 – 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Product
      3. By Grade
      4. By Application
      5. By Expression Host System
      6. By Mode of Action
      7. By Species Origin
      8. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 – 2032
      1. Transforming Growth Factors (TGF)
        1. Activin
        2. Bone Morphogenetic Proteins (BMPs)
        3. TGF-beta Proteins
      2. Epidermal Growth Factors (EGFs)
      3. Platelet-derived Growth Factors (PDGFs)
      4. Fibroblast Growth Factors (FGFs)
      5. Insulin-like Growth Factors (IGFs)
      6. Vascular Endothelial Growth Factors (VEGFs)
      7. Hepatocyte Growth Factors (HGFs)
      8. Tumor Necrosis Factors (TNFs)
      9. Interleukins
      10. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 – 2032
      1. GMP Grade
      2. NON-GMP Grade
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 – 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease and Diabetes
      6. Cell Therapy and EX-vivo Manufacturing
      7. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 – 2032
      1. Animal-derived
      2. Recombinant
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 – 2032
      1. Angiogenic
      2. Anti-apoptotic
      3. Mitogenic
    9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 – 2032
      1. Human
      2. Pig
      3. Mouse
      4. Rat
      5. Others
    10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 – 2032
      1. Pharmaceutical and Biotechnology Companies
      2. Research Centers and Academic Institutes
      3. Contract Research Organizations
    11. Market Attractiveness Analysis
  7. Europe Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Product
      3. By Grade
      4. By Application
      5. By Expression Host System
      6. By Mode of Action
      7. By Species Origin
      8. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 – 2032
      1. Transforming Growth Factors (TGF)
        1. Activin
        2. Bone Morphogenetic Proteins (BMPs)
        3. TGF-beta Proteins
      2. Epidermal Growth Factors (EGFs)
      3. Platelet-derived Growth Factors (PDGFs)
      4. Fibroblast Growth Factors (FGFs)
      5. Insulin-like Growth Factors (IGFs)
      6. Vascular Endothelial Growth Factors (VEGFs)
      7. Hepatocyte Growth Factors (HGFs)
      8. Tumor Necrosis Factors (TNFs)
      9. Interleukins
      10. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 – 2032
      1. GMP Grade
      2. NON-GMP Grade
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 – 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease and Diabetes
      6. Cell Therapy and EX-vivo Manufacturing
      7. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 – 2032
      1. Animal-derived
      2. Recombinant
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 – 2032
      1. Angiogenic
      2. Anti-apoptotic
      3. Mitogenic
    9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 – 2032
      1. Human
      2. Pig
      3. Mouse
      4. Rat
      5. Others
    10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 – 2032
      1. Pharmaceutical and Biotechnology Companies
      2. Research Centers and Academic Institutes
      3. Contract Research Organizations
    11. Market Attractiveness Analysis
  8. East Asia Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Product
      3. By Grade
      4. By Application
      5. By Expression Host System
      6. By Mode of Action
      7. By Species Origin
      8. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 – 2032
      1. Transforming Growth Factors (TGF)
        1. Activin
        2. Bone Morphogenetic Proteins (BMPs)
        3. TGF-beta Proteins
      2. Epidermal Growth Factors (EGFs)
      3. Platelet-derived Growth Factors (PDGFs)
      4. Fibroblast Growth Factors (FGFs)
      5. Insulin-like Growth Factors (IGFs)
      6. Vascular Endothelial Growth Factors (VEGFs)
      7. Hepatocyte Growth Factors (HGFs)
      8. Tumor Necrosis Factors (TNFs)
      9. Interleukins
      10. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 – 2032
      1. GMP Grade
      2. NON-GMP Grade
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 – 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease and Diabetes
      6. Cell Therapy and EX-vivo Manufacturing
      7. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 – 2032
      1. Animal-derived
      2. Recombinant
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 – 2032
      1. Angiogenic
      2. Anti-apoptotic
      3. Mitogenic
    9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 – 2032
      1. Human
      2. Pig
      3. Mouse
      4. Rat
      5. Others
    10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 – 2032
      1. Pharmaceutical and Biotechnology Companies
      2. Research Centers and Academic Institutes
      3. Contract Research Organizations
    11. Market Attractiveness Analysis
  9. South Asia & Oceania Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Product
      3. By Grade
      4. By Application
      5. By Expression Host System
      6. By Mode of Action
      7. By Species Origin
      8. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 – 2032
      1. Transforming Growth Factors (TGF)
        1. Activin
        2. Bone Morphogenetic Proteins (BMPs)
        3. TGF-beta Proteins
      2. Epidermal Growth Factors (EGFs)
      3. Platelet-derived Growth Factors (PDGFs)
      4. Fibroblast Growth Factors (FGFs)
      5. Insulin-like Growth Factors (IGFs)
      6. Vascular Endothelial Growth Factors (VEGFs)
      7. Hepatocyte Growth Factors (HGFs)
      8. Tumor Necrosis Factors (TNFs)
      9. Interleukins
      10. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 – 2032
      1. GMP Grade
      2. NON-GMP Grade
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 – 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease and Diabetes
      6. Cell Therapy and EX-vivo Manufacturing
      7. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 – 2032
      1. Animal-derived
      2. Recombinant
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 – 2032
      1. Angiogenic
      2. Anti-apoptotic
      3. Mitogenic
    9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 – 2032
      1. Human
      2. Pig
      3. Mouse
      4. Rat
      5. Others
    10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 – 2032
      1. Pharmaceutical and Biotechnology Companies
      2. Research Centers and Academic Institutes
      3. Contract Research Organizations
    11. Market Attractiveness Analysis
  10. Latin America Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Product
      3. By Grade
      4. By Application
      5. By Expression Host System
      6. By Mode of Action
      7. By Species Origin
      8. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 – 2032
      1. Transforming Growth Factors (TGF)
        1. Activin
        2. Bone Morphogenetic Proteins (BMPs)
        3. TGF-beta Proteins
      2. Epidermal Growth Factors (EGFs)
      3. Platelet-derived Growth Factors (PDGFs)
      4. Fibroblast Growth Factors (FGFs)
      5. Insulin-like Growth Factors (IGFs)
      6. Vascular Endothelial Growth Factors (VEGFs)
      7. Hepatocyte Growth Factors (HGFs)
      8. Tumor Necrosis Factors (TNFs)
      9. Interleukins
      10. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 – 2032
      1. GMP Grade
      2. NON-GMP Grade
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 – 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease and Diabetes
      6. Cell Therapy and EX-vivo Manufacturing
      7. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 – 2032
      1. Animal-derived
      2. Recombinant
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 – 2032
      1. Angiogenic
      2. Anti-apoptotic
      3. Mitogenic
    9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 – 2032
      1. Human
      2. Pig
      3. Mouse
      4. Rat
      5. Others
    10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 – 2032
      1. Pharmaceutical and Biotechnology Companies
      2. Research Centers and Academic Institutes
      3. Contract Research Organizations
    11. Market Attractiveness Analysis
  11. Middle East & Africa Growth Factors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 – 2024
      1. By Country
      2. By Product
      3. By Grade
      4. By Application
      5. By Expression Host System
      6. By Mode of Action
      7. By Species Origin
      8. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 – 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 – 2032
      1. Transforming Growth Factors (TGF)
        1. Activin
        2. Bone Morphogenetic Proteins (BMPs)
        3. TGF-beta Proteins
      2. Epidermal Growth Factors (EGFs)
      3. Platelet-derived Growth Factors (PDGFs)
      4. Fibroblast Growth Factors (FGFs)
      5. Insulin-like Growth Factors (IGFs)
      6. Vascular Endothelial Growth Factors (VEGFs)
      7. Hepatocyte Growth Factors (HGFs)
      8. Tumor Necrosis Factors (TNFs)
      9. Interleukins
      10. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Grade, 2025 – 2032
      1. GMP Grade
      2. NON-GMP Grade
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 – 2032
      1. Oncology
      2. Hematology
      3. Wound Healing
      4. Dermatology
      5. Cardiovascular Disease and Diabetes
      6. Cell Therapy and EX-vivo Manufacturing
      7. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Expression, 2025 – 2032
      1. Animal-derived
      2. Recombinant
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Mode of Action, 2025 – 2032
      1. Angiogenic
      2. Anti-apoptotic
      3. Mitogenic
    9. Current Market Size (US$ Mn) Analysis and Forecast, By Species Origin, 2025 – 2032
      1. Human
      2. Pig
      3. Mouse
      4. Rat
      5. Others
    10. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 – 2032
      1. Pharmaceutical and Biotechnology Companies
      2. Research Centers and Academic Institutes
      3. Contract Research Organizations
    11. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Thermo Fisher Scientific, Inc.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Merck KGaA
      3. Bio-Rad Laboratories, Inc.
      4. Lonza Group AG
      5. F. Hoffmann-La Roche Ltd.
      6. Sartorius CellGenix GmbH
      7. Bio-Techne Corporation
      8. GenScript
      9. Miltenyi Biotec.
      10. Abcam PLC
      11. Sino Biological Inc.
      12. Cell Signaling Technology, Inc.
      13. ACROBiosystems
      14. Becton, Dickinson, and Company
      15. Creative Bioarray
      16. Applied Biological Materials (abm) Inc.
      17. GE Healthcare
      18. Meridian Bioscience Inc.
      19. Repligen Corporation
      20. Aviva Systems Biology Corporation (GenWay Biotech)
      21. Leadgene Biomedical, Inc.
      22. Boster Bio
      23. Prospec-Tany Technogene Ltd.
      24. Proteintech Group, Inc.
      25. AJINOMOTO CO., Inc.
      26. STEMCELL Technologies
      27. Akron Biotech
      28. PeproTech Inc.
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

Thank you for taking time to visit our website, click like if you found the information on this page useful?

View All Reports
Research Methodology
Contact Us
This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate